Production & Manufacturing
Production & Manufacturing
Bone Therapeutics to build new manufacturing facility in Belgium
Biopharmaceutical company Bone Therapeutics has announced that it has made a €10m investment in Skeletal Cell Therapy Support (SCTS) to build a new manufacturing facility at Gosselies Scientific Park near Brussels in Belgium. The...
Production & Manufacturing
Qualicaps to invest $26m for Whitsett facility expansion
Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina in the US. Under the expansion plans, the firm will also add additional 100,000 ft² building space. The project will...
Production & Manufacturing
PCT to provide development, manufacturing services to Adaptimmune
Progenitor Cell Therapy (PCT), a subsidiary of NeoStem, has signed an agreement to provide cell product development and manufacturing services for Adaptimmune's clinical trials. Adaptimmune will make use of PCT services in the development...
Production & Manufacturing
Amgen to invest $200m in new Singapore manufacturing facility
Amgen is planning to invest $200m to construct a manufacturing facility in the Tuas Biomedical Park area of Singapore. Company intends to begin the construction of the new facility shortly to expand the monoclonal...
Production & Manufacturing
Impax, Perrigo to jointly develop topical generic drug
Impax Laboratories and Perrigo Company have signed a deal to develop and manufacture an undisclosed topical generic drug. The terms of the deal that also involves marketing of the extended topical generic product were...
Production & Manufacturing
Fujifilm to manufacture bulk substance for ThromboGenics’ eye medication
Fujifilm Diosynth Biotechnologies will manufacture the bulk substance for ThromboGenics' FDA approved Jetrea (ocriplasmin) indicated for symptomatic vitreomacular adhesion (VMA). The companies signed a long-term supply agreement in September 2010 and worked towards completing...
Production & Manufacturing
Mylan Labs to buy SMS Indian manufacturing unit
Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m). The manufacturing unit was designed for the production of cancer medications and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read